BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36146876)

  • 1. COS-7 and SVGp12 Cellular Models to Study JCPyV Replication and MicroRNA Expression after Infection with Archetypal and Rearranged-NCCR Viral Strains.
    Prezioso C; Passerini S; Limongi D; Palamara AT; Moens U; Pietropaolo V
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should SVGp12 Be Used for JC Polyomavirus Studies? Comment on Prezioso et al. COS-7 and SVGp12 Cellular Models to Study JCPyV Replication and MicroRNA Expression after Infection with Archetypal and Rearranged-NCCR Viral Strains.
    Henriksen S; Rinaldo CH
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COS-7 cells are a cellular model to monitor polyomavirus JC miR-J1-5p expression.
    Agostini S; Mancuso R; Costa AS; Guerini FR; Clerici M
    Mol Biol Rep; 2020 Nov; 47(11):9201-9205. PubMed ID: 33085050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyomavirus JC microRNA expression after infection in vitro.
    Giovannelli I; Clausi V; Nukuzuma S; Della Malva N; Nosi D; Giannecchini S
    Virus Res; 2016 Feb; 213():269-273. PubMed ID: 26763354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of JC polyomavirus-encoded microRNAs in progressive multifocal leukoencephalopathy tissues and its repressive role in virus replication.
    Takahashi K; Sato Y; Sekizuka T; Kuroda M; Suzuki T; Hasegawa H; Katano H
    PLoS Pathog; 2020 Apr; 16(4):e1008523. PubMed ID: 32324824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reply to Henriksen, S.; Rinaldo, C.H. Should SVGp12 Be Used for JC Polyomavirus Studies? Comment on "Prezioso et al. COS-7 and SVGp12 Cellular Models to Study JCPyV Replication and MicroRNA Expression after Infection with Archetypal and Rearranged-NCCR Viral Strains.
    Prezioso C; Moens U; Pietropaolo V
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of COS-JC cells persistently producing archetype JC polyomavirus.
    Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Hidaka K; Takegami T
    Microbiol Immunol; 2018 Aug; 62(8):524-530. PubMed ID: 29932215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of JC Polyomavirus Derived from COS-IMRb Cells.
    Nukuzuma S; Nukuzuma C; Kameoka M; Sugiura S; Nakamichi K; Tasaki T; Hidaka K; Takegami T
    Jpn J Infect Dis; 2021 Jan; 74(1):48-53. PubMed ID: 32741932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The JCPYV DNA load inversely correlates with the viral microrna expression in blood and cerebrospinal fluid of patients at risk of PML.
    Rocca A; Martelli F; Delbue S; Ferrante P; Bartolozzi D; Azzi A; Giannecchini S
    J Clin Virol; 2015 Sep; 70():1-6. PubMed ID: 26305810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient propagation of archetype JC polyomavirus in COS-7 cells: evaluation of rearrangements within the NCCR structural organization after transfection.
    Prezioso C; Scribano D; Bellizzi A; Anzivino E; Rodio DM; Trancassini M; Palamara AT; Pietropaolo V
    Arch Virol; 2017 Dec; 162(12):3745-3752. PubMed ID: 28884263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of human neurotropic JCPyV DNA sequence in pediatric anaplastic xanthoastrocytoma.
    Passerini S; Prezioso C; Prota A; Babini G; Bargiacchi L; Bartolini D; Moens U; Antonelli M; Pietropaolo V
    J Neurovirol; 2023 Apr; 29(2):232-236. PubMed ID: 37097595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human iPS cell-derived astrocytes support efficient replication of progressive multifocal leukoencephalopathy-type JC polyomavirus.
    Shimbo E; Nukuzuma S; Tagawa YI
    Biochem Biophys Res Commun; 2020 Dec; 533(4):983-987. PubMed ID: 33008586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study.
    Bellizzi A; Anzivino E; Rodio DM; Cioccolo S; Scrivo R; Morreale M; Pontecorvo S; Ferrari F; Di Nardo G; Nencioni L; Carluccio S; Valesini G; Francia A; Cucchiara S; Palamara AT; Pietropaolo V
    Virol J; 2013 Sep; 10():298. PubMed ID: 24079660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BK Polyomavirus MicroRNA Levels in Exosomes Are Modulated by Non-Coding Control Region Activity and Down-Regulate Viral Replication When Delivered to Non-Infected Cells Prior to Infection.
    Martelli F; Wu Z; Delbue S; Weissbach FH; Giulioli MC; Ferrante P; Hirsch HH; Giannecchini S
    Viruses; 2018 Aug; 10(9):. PubMed ID: 30200237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Assessment of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients during 1 Year of Ocrelizumab Treatment.
    Prezioso C; Grimaldi A; Landi D; Nicoletti CG; Brazzini G; Piacentini F; Passerini S; Limongi D; Ciotti M; Palamara AT; Marfia GA; Pietropaolo V
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JCPyV NCCR analysis in PML patients with different risk factors: exploring common rearrangements as essential changes for neuropathogenesis.
    Ciardi MR; Zingaropoli MA; Iannetta M; Prezioso C; Perri V; Pasculli P; Lichtner M; d'Ettorre G; Altieri M; Conte A; Pietropaolo V; Mastroianni CM; Vullo V
    Virol J; 2020 Feb; 17(1):23. PubMed ID: 32046748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rate.
    Gosert R; Kardas P; Major EO; Hirsch HH
    J Virol; 2010 Oct; 84(20):10448-56. PubMed ID: 20686041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFNα and β Mediated JCPyV Suppression through C/EBPβ-LIP Isoform.
    May D; Bellizzi A; Kassa W; Cipriaso JM; Caocci M; Wollebo HS
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis?
    Prezioso C; Zingaropoli MA; Iannetta M; Rodio DM; Altieri M; Conte A; Vullo V; Ciardi MR; Palamara AT; Pietropaolo V
    Mult Scler Relat Disord; 2020 Jun; 41():102008. PubMed ID: 32087593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Molecule Sequencing Revealing the Presence of Distinct JC Polyomavirus Populations in Patients With Progressive Multifocal Leukoencephalopathy.
    Seppälä H; Virtanen E; Saarela M; Laine P; Paulín L; Mannonen L; Auvinen P; Auvinen E
    J Infect Dis; 2017 Mar; 215(6):889-895. PubMed ID: 28453853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.